Loading…
Alamar Biosciences, Inc. is projected to rise to $30.27 by 2027, a +21% move from its current price of $25.07. ALMR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $24.26 | $25.09 | $25.95 | +0.09% |
| Aug 2 | $23.95 | $25.11 | $26.33 | +0.18% |
| Aug 3 | $23.72 | $25.14 | $26.64 | +0.27% |
| Aug 4 | $23.53 | $25.16 | $26.90 | +0.35% |
| Aug 5 | $23.36 | $25.18 | $27.14 | +0.44% |
| Aug 6 | $23.22 | $25.20 | $27.36 | +0.53% |
| Aug 7 | $23.08 | $25.23 | $27.56 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.08 | $25.23 | $27.56 | +0.62% |
| Week 2 | $22.39 | $25.38 | $28.77 | +1.24% |
| Week 3 | $21.90 | $25.54 | $29.78 | +1.87% |
| Week 4 | $21.52 | $25.70 | $30.68 | +2.50% |
| Week 5 | $21.21 | $25.86 | $31.53 | +3.14% |
| Week 6 | $20.94 | $26.02 | $32.33 | +3.78% |
| Week 7 | $20.70 | $26.18 | $33.10 | +4.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alamar Biosciences, Inc. (ALMR) is a proteomics company that develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.
It develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.
The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally.
The company was incorporated in 2018 and is based in Fremont, California.
The stock trades with a current price of $24.95 and a market cap of $1.73B. It is ranked 2123.
The near-term forecast shows 2026 with a min of $19.09, an avg of $24.95, and a max of $37.94, with ROI of 0 and sentiment Neutral. The 2027‑2030 stretch carries bullish sentiment and rising averages, reaching a 2030 avg of $65.97 and max of $113.75 with ROI of 164.4.
For the longer horizon, the forecast climbs to a 2040 avg of $208.74 with a max of $454.23 (ROI 736.6) and a 2050 avg of $523.03 with a max of $1,202.97 (ROI 1996.3). The sentiment remains BULLISH across the latter years.
A major floor 34.8% below — a decisive break under it would weaken the trend.
The nearest floor, 19.4% below — buyers have tended to step in here.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 30.8% above — clearing it would confirm fresh momentum.
Key ALMR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALMR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.89 | Buy | $24.90 | Buy |
| MA 10 | $25.05 | Buy | $25.11 | Sell |
| MA 20 | $25.65 | Sell | $25.12 | Sell |
| MA 50 | $23.41 | Buy | $24.27 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.79 | Neutral |
| Stoch RSI (14) | 26.27 | Neutral |
| CCI (20) | -46.72 | Neutral |
| Williams %R (14) | -66.95 | Info |
| MACD (12,26,9) | -0.28 | Sell |
| ROC (12) | -7.32 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 33.05 | Neutral |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 46.12 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 24.50 | Buy |
| ADX (14) | 12.06 | Neutral |
| ATR (14) | 0.79 | Info |
The 30-day technical picture is bullish overall. RSI14 sits at 50, suggesting neutral momentum with a slight bullish tilt, while the price trades above the 50-day simple moving average of $23.00.
Key support sits at $19.21 and resistance at $28.42, with a 30-day price range of $19.82 to $31.41. Annualized volatility is elevated at 70%, underscoring notable price movement potential in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.09 | $25.07 | $38.01 | 0% | Neutral | |
| $22.29 | $30.27 | $44.36 | +21% | Bullish | |
| $27.85 | $40.04 | $62.41 | +60% | Bullish | |
| $38.15 | $57.58 | $94.08 | +130% | Bullish | |
| $39.98 | $63.03 | $107.08 | +151% | Bullish | |
| $44.20 | $72.57 | $127.49 | +189% | Bullish | |
| $47.66 | $81.35 | $147.20 | +224% | Bullish | |
| $46.87 | $83.02 | $154.27 | +231% | Bullish | |
| $52.92 | $97.17 | $184.98 | +288% | Bullish | |
| $57.63 | $109.58 | $213.31 | +337% | Bullish | |
| $83.46 | $185.46 | $395.62 | +640% | Bullish | |
| $212.17 | $471.49 | $1,084.43 | +17.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.09 | $25.07 | $29.42 | +0.00% |
| August 2026 | $22.47 | $26.85 | $33.17 | +7.08% |
| September 2026 | $22.39 | $27.17 | $34.38 | +1.22% |
| October 2026 | $22.08 | $27.14 | $34.99 | -0.11% |
| November 2026 | $22.71 | $28.21 | $36.92 | +3.96% |
| December 2026 | $22.85 | $28.66 | $38.01 | +1.57% |
Click any year to see its month-by-month ALMR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ALMR is projected to trade between $19.09 and $38.01, averaging $25.07 — a potential gain of 0% from today's $25.07. A consolidation phase looks the most probable path here.
Alamar Biosciences, Inc.'s 2027 outlook centres on $30.27, within a $22.29 to $44.36 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2028, ALMR could reach as high as $62.41, with a base case around $40.04 and support toward $27.85 — roughly +60% from $25.07. Buyers look set to stay in control over this stretch.
Expect ALMR to range from $38.15 to $94.08 through 2029. The $57.58 average target implies a +130% move from current prices. That is up +44% on the projected 2028 average. Momentum favours further upside here.
The ALMR price prediction for 2030 points to an average of $63.03 (low $39.98, high $107.08) — a potential gain of +151% on today's $25.07. Buyers look set to stay in control over this stretch.
In 2031, ALMR is projected to trade between $44.20 and $127.49, averaging $72.57 — a potential gain of +189% from today's $25.07. That is up +15% on the projected 2030 average. Momentum favours further upside here.
Alamar Biosciences, Inc.'s 2032 outlook centres on $81.35, within a $47.66 to $147.20 range. That is up +12% on the projected 2031 average. That marks a +224% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ALMR could reach as high as $154.27, with a base case around $83.02 and support toward $46.87 — roughly +231% from $25.07. Momentum favours further upside here.
Expect ALMR to range from $52.92 to $184.98 through 2034. The $97.17 average target implies a +288% move from current prices. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ALMR price prediction for 2035 points to an average of $109.58 (low $57.63, high $213.31) — a potential gain of +337% on today's $25.07. Momentum favours further upside here.
In 2040, ALMR is projected to trade between $83.46 and $395.62, averaging $185.46 — a potential gain of +640% from today's $25.07. That is up +69% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Alamar Biosciences, Inc.'s 2050 outlook centres on $471.49, within a $212.17 to $1,084.43 range. That is up +154% on the projected 2040 average. That marks a +17.8x change versus current levels. Momentum favours further upside here.
Investing $1,000 in ALMR today (≈ 39.888313 ALMR) could be worth
$18,807.01
+$17,807.01 (+1781%) by 2050 · US Dollar
Based on the average projected ALMR price of $471.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMRwould be worth at today's price.
$1,000 invested in ALMR on Apr 17, 2026 (≈ 45.454545 ALMR) would be worth
$1,139.55
+$139.55 (+14.0%) today · 1.14× · US Dollar
Based on a ALMR entry price of $22 vs. today's $25.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.89 | $968.33 | -3.2% |
| 1 month ago | $27.09 | $925.43 | -7.5% |
| 3 months ago | $25.81 | $971.33 | -2.9% |
| All time ago | $22 | $1,139.55 | +14.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMR forecast.
Our base-case forecast reaches $50.00 around 2029.
Implied market cap at $50.00: $3.47B
The multi-year outlook shows a clear upward trajectory after 2026, with 2027 averaging $30.79 (max $45.65, ROI 23.4) and strengthening bullish sentiment into 2028 ($42.51 avg, max $67.13; ROI 70.4) and 2029 ($60.14 avg, max $99.66; ROI 141.1).
By 2030 the average is projected at $65.97 with a max of $113.75 (ROI 164.4) and ongoing bullish momentum through 2040 (avg $208.74, max $454.23; ROI 736.6). The 2050 forecast shows an average of $523.03 and a max of $1,202.97 (ROI 1996.3), continuing the bullish trajectory.
These are estimates, not guarantees. As with all forecasts, actual results will be influenced by market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $65.97 with a min of $41.11, a max of $113.75 and ROI of 164.4%; sentiment is BULLISH.
The forecast indicates bullish potential beyond 2026, with 2027–2030 showing rising averages and a 2030 avg of $65.97 and 2050 avg of $523.03; 2026 is Neutral. Remember these are estimates, not guarantees.
Yes. The forecast max in 2050 is $1,202.97.
Current price is $24.95 and market cap is $1.73B.
Sentiment is BULLISH; RSI14 is 50; SMA50 is $23.00; 30-day range is $19.82-$31.41; support is $19.21 and resistance is $28.42; annualized volatility is 70%.
Alamar Biosciences, Inc. Community Discussion
0Share your Alamar Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.